奥氮平治疗脑血管病所致精神障碍的对照研究  

Control Study of Olanzapine in Treatment of Mental Disorders Caused by Cerebrovascular Disease

作　　者：王玲[1] 

机构地区：[1]河南省洛阳市精神卫生中心综合内科,471000

出　　处：《中国继续医学教育》2015年第30期128-129,共2页China Continuing Medical Education

摘　　要：目的探讨脑血管病所致精神障碍患者采取奥氮平治疗的效果。方法脑血管病所致精神障碍患者80例均分为2组,对照组予以利培酮治疗,研究组予以奥氮平治疗,对比两组效果。结果两组总有效率、总不良反应发生率无统计学意义(P>0.05),但静坐不能、失眠、嗜睡、体重增加有差异(P<0.05)。结论脑血管病所致精神障碍患者采取奥氮平治疗可取得较好疗效。Objective To investigate the mental disorders caused by cerebrovascular disease taking olanzapine treatment effect.Methods80 patients with mental disorders due to cerebral vascular disease were divided into 2 groups, patients in control group were given risperidone in the treatment of, the research group to be olanzapine treatment, compared two groups effect.ResultsThere was no signiifcant difference in total effective rate and total adverse reaction rate （P〉0.05） in the two groups, but there was no difference in the, insomnia, sleepiness and weight gain （P〈0.05）. Conclusion Mental disorders due to cerebral vascular disease patients taking olanzapine treatment can achieve good curative effect.

关 键 词：脑血管病 精神障碍 奥氮平 

分 类 号：R743[医药卫生—神经病学与精神病学]